Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
KPRXKiora Pharmaceuticals Inc
| Figure | KPRXKiora Pharmaceuticals IncFY2025 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | −100.0% |
| Net income | $10.84M |
| Net income, yoy | −401.4% |
| Net margin | — |
| Free cash flow | $10.07M |
| FCF margin | — |
| EPS, diluted | $2.64 |
Add another company.
Annual · FY2020–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed